Trauma, Head Clinical Trial
Official title:
Effects of Repetitive Subconcussive Head Impacts on Ocular-motor Function and Brain-derived Blood Biomarker
NCT number | NCT03488381 |
Other study ID # | 1610743422 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 1, 2017 |
Est. completion date | April 9, 2019 |
Verified date | April 2019 |
Source | Indiana University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Repetitive head impacts in sports and military may cause deleterious effects in the nervous system. Investigators' previous works in football players have shown promising results in prediction of concussion and prevention of long-term defect using eye-movement paradigm (ocular-motor system) and blood biomarker. However, acute head impact effects on aforementioned parameters remain unknown. Thus, to answer a critical research question that whether or not ocular-motor system and brain-derived blood biomarker may be acutely altered following 10 successions of controlled soccer heading. To answer the question, investigators hypothesized that acute bout of soccer heading will not elicit noticeable change in subject's symptoms but to induce a transient defect in the ocular-motor system and increase plasma expression of brain-derived biomarker.
Status | Completed |
Enrollment | 45 |
Est. completion date | April 9, 2019 |
Est. primary completion date | April 9, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 26 Years |
Eligibility |
Inclusion Criteria: For Soccer Cohort 1. being between 18 to 26 years of age 2. an active member of a soccer team (i.e., collegiate, intramural, club, professional) 3. at least 5 years of soccer heading experience. For non-Athletic Control Cohort 1. Being between 18 to 26 years of age 2. Have never played organized sports 3. Have never been diagnosed with a concussion Exclusion Criteria: For both Soccer and Non-Athletic Control cohorts 1. any head, neck, or face injury in the 1 year prior to the study (e.g., concussion, eye injury); 2. history of vestibular, ocular, or vision dysfunction (e.g., macular degeneration) 3. currently taking any medications affecting balance (e.g., antibiotics) 4. pregnancy 5. HIV 6. any neurological disorders (e.g., seizure disorders, closed head injuries with loss of consciousness greater than 15 minutes, CNS neoplasm, spinal cord injury/surgery, history of stroke) 7. hypertension, cardiac arrhythmia, or pulmonary disease 8. lower extremity injury that would prohibit normal walking 9. metal implants in the head 10. implantation of cochlear device, cardiac pacemaker, medical fusion device, intracardiac lines, or neurostimulator (e.g., DBS, epidural/subdural VNS) 11. history of severe injury to the bones, joints, or muscles in either arm Session-specific exclusion criteria will include: 12. slept less than 4 hours before the 1st and 2nd test day (verified by the TMS screening questionnaire) 13. drank more than 3 alcoholic drinks or used recreational drugs 24 hours before the 1st and 2nd test day 14. drank more than 3 cups of coffee in an hour before test sessions 15. glasses are prohibited (contact lens are okay) for safety purpose for the heading intervention |
Country | Name | City | State |
---|---|---|---|
United States | Indiana University | Bloomington | Indiana |
Lead Sponsor | Collaborator |
---|---|
Indiana University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in Brain-Derived Blood Biomarker Over Time in Relation to the Baseline | Outcome measure will be the slope of increased (worsened) levels of blood biomarkers compared to the baseline and control group | Measured at four time points (pre-intervention, immediately post-intervention, 2 hours post, and 24 post) | |
Primary | Changes in Ocular-Motor Function Over Time in Relation to the Baseline | Outcome measure will be the slope of increased (worsened) levels of ocular-motor performance compared to the baseline and control group | Measured at four time points (pre-intervention, immediately post-intervention, 2 hours post, and 24 post) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04505293 -
Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas
|
N/A | |
Recruiting |
NCT03721354 -
Comparison Between NAVA and PSV in Neurocritical Patients
|
N/A | |
Recruiting |
NCT04489160 -
Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury
|
Phase 2 | |
Not yet recruiting |
NCT06245967 -
Frequency Specific Microcurrent Therapy for Mild Traumatic Brain Injury
|
N/A | |
Completed |
NCT03566368 -
Cardiac Dysfunction in Traumatic Brain Injury
|
||
Completed |
NCT03353246 -
Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas
|
N/A |